Optimizing the Conditioning Regimen for HCT in Myelofibrosis: Long-term Results of a Prospective Phase II Clinical Trial

BACKGROUND: Optimal conditioning regimen for older patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation (HCT) is not known. Likewise, role of dose intensity is not clear. METHODS: We conducted a non-randomized prospective phase II trial using low-dose, later escalated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biol Blood Marrow Transplant
Autores principales: Popat, Uday, Mehta, Rohtesh S., Bassett, Roland, Kongtim, Piyanuch, Chen, Julianne, Alousi, Amin M., Anderlini, Paolo, Ciurea, Stefan, Hosing, Chitra, Jones, Roy, Kebriaei, Partow, Khouri, Issa, Lindsay, Richard, Nieto, Yago, Olson, Amanda, Oran, Betul, Qazilbash, Muzaffar H., Rondon, Gabriela, Shpall, Elizabeth J., Verstovsek, Srdan, Andersson, Borje S., Champlin, Richard E.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2020
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7547798/
https://ncbi.nlm.nih.gov/pubmed/32438043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.03.020
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares